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SUMMARY
The combination of evidence from independent studies has a curious history. The origins
reach back at least to the beginning of the twentieth century. Since the mid-seventies
the term meta-analysis (G. Glass, 1976 presidential address to the American Educational
Research Association) has become popular in several fields, among them medical statistics
and the behavioral sciences. The most widely used procedures were perfected in early
papers and subsequently a kind of groupthink has taken hold of meta-analysis. This
explains the need for a review in a statistics journal, destined for a statistical audience.
Meta-analysis is not a hot research topic among graduate students in statistics and by
writing this article we hope to change this. We wish to point out the shortcomings of
the mainstream view and exhibit some of the open problems that await the attention of
statistical researchers.
A host of competent reviews of meta-analysis have been published and several book-
length treatments are also available. We have listed many of these in the bibliography, but
cannot guarantee completeness.
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RE´SUME´
La mise en commun des re´sultats de plusieurs e´tudes individuelles portant sur la meˆme
question posse`de une droˆle d’historique. Les de´buts remontent au de´but du 20e sie`cle.
Depuis le milieu des anne´es septantes le terme me´ta-analyse (G. Glass, 1976 discours pres-
identiel lors de la confe´rence de l’American Educational Research Association) est devenu
populaire dans plusieurs domaines, entre autres la statistique me´dicale et les sciences du
comportement et de psychologie. Les me´thodes les plus utilise´es ont e´te´ e´labore´es assez
vite et ensuite une sorte de pense´e unique s’est empare´e de la me´ta-analyse. Cela ex-
plique la ne´cessite´ d’un bilan dans un journal de´stine´ a` un publique de statisticien(ne)s.
La me´ta-analyse n’est pas un sujet appre´cie´ par nos e´tudiants doctorants et nous espe´rons
de changer cela avec cet article. Nous voulons montrer les points faibles de l’approche
habituelle et explorer quelques proble`mes ouverts qui posent des de´fis aux chercheurs en
statistique.
Une se´rie de bilans compe´tents de la me´ta-analyse ont e´te´ publie´s et plusieurs livres
sont e´galement a` disposition. Notre article fait re´fe´rence a` beaucoup d’entre eux, mais
nous avons suˆrement oublie´ quelques-uns.
Mots cle´s: bilan, me´ta-analyse, ampleur de l’effet, effets ale´atoires, me´ta-re´gression,
logiciels
1 Introduction
The broad aim of a meta-analysis (MA) is to provide a review of the literature on some
scientific question and to summarize the information in a quantitative manner. It is hoped
that by combining the statistical evidence from all the available studies a stronger consensus
view can emerge. Meta-analysis taken in this sense is merely a part of a systematic review,
which involves an extensive methodology for research synthesis going beyond meta-analysis.
A systematic review requires the identification of the relevant studies, the determination
how each study was conducted and under what precise circumstances, the collection of the
associated data , the evaluation of the study quality, etc. But it is fair to say that unless the
statistical methods being used are sound, the numerical summaries from a meta-analysis
may be misleading and no benefits may accrue from combining the studies.
Each study or trial used in a meta-analysis is summarized by an estimate of an appropri-
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ate effect, for example, the odds-ratio when comparing two samples with binary outcomes,
or the mean, when the study consists of a single sample with continuous outcomes, and
so on. The meta-analysis attempts to provide a more precise estimate. The single most
important reason for failures in meta-analyses are biases. Many estimators, for example,
are biased when applied to finite samples. Combining even a very large number of finite
sample estimates does not make this bias disappear. On the contrary, its relative impor-
tance grows, because the variance decreases towards zero by combining studies. Another
example are study-related biases. Does it makes sense to estimate an overall effect via a
meta-analysis? To what populations will the result apply? Sequences of studies are usually
done with differing standards, different definitions and methods, different populations, and
so on. Sometimes, covariates may help in explaining the differences at least partially. In
other instances it might be better to refrain from attempting a combination. Yet other
biases are more subtle. Difficulties in publishing papers with insignificant findings, for
example, will result in publication bias which exaggerates the true effect. The history of
science provides many examples in which statistically significant effects were identified,
published and even celebrated, only to be refuted later on. It seems all too easy to arrive
at such wrong conclusions, particularly if the effect is believed to be real by the scientific
community. Statisticians have already contributed to the resolution of publication bias
(see Section 3), but much more needs to be done.
The second order effects, such as variances or lengths of confidence intervals, are of
lesser importance, but nevertheless deserve attention. One should make sure that all
sources of variation are accounted for when computing the variance of an estimated effect.
The resulting confidence intervals will be wider, but also more realistic. It clearly would
also be desirable to include potential biases when calculating confidence intervals. But this
requires a rethink of our current theories of testing and inference.
In view of the unmet needs in the area of bias and variance, it seems almost unnecessary
to talk about the higher order effects due to deviations from Gaussianity. Clearly, however,
more accurate models will lead to more accurate inferences and it presumably would be
useful for meta-analysis to use more sophisticated models.
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1.1 A very brief history of meta-analysis
An early paper is an investigation reported in Simpson and Pearson (1904) of correlation
coefficients in 2× 2 contingency tables of incidence or survival vs. inoculation. Data sets
from South Africa and India are taken into consideration and the paper’s main achieve-
ments are the organization and reduction of the data into comparable form and the sum-
mary of the data via a correlation coefficient with accompanying probable error. The only
meta-statistic Simpson and Pearson present is the mean across the data sets. One of the
conclusions of the paper states that “To sum up, it seems that, while most of the cor-
relations both for immunity and recovery are distinctly sensible, having regard to their
probable error, yet they are so irregular that little reliance can be placed upon them as
representing a definitive uniform effect.” (Simpson and Pearson, 1904, p. 1244). This
remains a valid statement of one of the main difficulties one encounters when combining
estimated effects.
The analysis of variance, a technique developed by R.A. Fisher in the nineteen-thirties,
can be seen as a basic tool for meta-analysis. The simplest case concerns several paral-
lel samples (1-way ANOVA), with the factor denoting the studies. The common mean
represents the common effect, while the individual study effects can be used to assess the
variation between studies. The residual variation, finally, is a measure of the within study
variation. The first papers written from this point of view appeared in the late thirties
(Cochran, 1937; Yates and Cochran, 1938). In Cochran’s paper a setup is introduced that
is still in use today. The individual samples – or centres as he calls them – are summarized
by the effect estimate xi (the mean) and its standard error si based on a known number
of degrees of freedom. An even simpler summary – merely a p-value of a significance test
for a null hypothesis common to all centers — was discussed in Tippett et al. (1931) and
Fisher (1932). They proposed methods for computing a combined p-value.
For most statisticians, meta-analysis became an area to avoid, perhaps because they
mistakenly thought that such analyses were straightforward. Notable exceptions include
Gene V. Glass, Larry Hedges, and Ingram Olkin.
1.2 Data in a typical meta-analysis
It is of interest to understand what data constitutes a ‘typical’ meta-analysis. We analysed
all meta-analyzes using the difference of means as an effect measure from issue 4 of the
4
Cochrane database (2004, compact disk edition). All these studies have two arms: a
treatment and a control arm with sample sizes denoted be nT and nC , respectively, with
the overall sample size n = nT + nC . The data consists of sample means and sample
variances in the two arms. There were 4,585 meta-analyses having K > 1 studies and
positive variances in both arms. Interestingly, the numbers of studies per meta-analysis
are small: 47% with K = 2, 21% with K = 3, and in total 95% with K ≤ 8, though the
maximum was K = 58.
An assumption often taken for granted in theoretical work is that of large sample sizes.
In fact, the majority of meta-analyses include some small studies. The minimum study size
is 20 or less in 25% of meta-analyses; ≤ 33 in 50%, and ≤ 70 in 75%. Often all studies in a
meta-analysis are rather small: maximum study size is 50 or less in 25% of meta-analyses
and less than ≤ 110 in 50%. Only 10% of the meta-analyses include one or more studies
of 490 or more patients. The majority of the studies are fairly balanced: in 75% of the
meta-analyses min{nT/n, nC/n} ≥ 0.44, and only in 10% min{nT/n, nC/n} ≤ 0.33.
1.3 What is to come
The paper offers a review of the procedures and open problems in statistical meta-analysis.
This is a topic of growing importance, because in many areas of application the need for
combining different sources of data and different sources of information in order to reach
an overall assessment manifests itself. The classical material on meta-analytic statistical
procedures are reviewed in Section 2. These include the distinction between fixed and
random effects models, tests of homogeneity, meta-regression, observational studies, and a
discussion of the types of data typically available for a meta-analysis. Section 3 investigates
two sources of bias in meta-analysis, the bias due to the systematic selection of studies
showing stronger than average effects, and the meta-analysis of smallish studies combined
with the use of estimators with appreciable small sample biases. In Sections 4 and 5
generalizations and extensions to the standard procedures are discussed. They include
multivariate responses and sequential procedures. A non-exhaustive list of software tools
closes out the review.
5
2 Models for meta-analysis and meta-regression
For a statistician, standard meta-analysis is very close to fixed or random effects 1-way
ANOVA under heteroscedasticity, complicated by mere asymptotic rather than exact nor-
mality of the participating statistics. A closely linked area is the analysis of interlaboratory
studies. Exact distributional results do not exist in a closed form, and various approxima-
tions are in use. There are three possible ways to derive these approximations: increasing
within-study sample sizes nk →∞ for a fixed number of studies K; increasing number of
studies K → ∞ for fixed or bounded study sizes; and also for both K and nk increasing
simultaneously. These three options are often erroneously interchanged. As we shall see,
they result in very different inferential procedures.
A reader who is interested in more detailed information about meta-analysis, can con-
sult one of the recently published books on the subject. Here is a selection in chronological
order: Hedges and Olkin (1985), Wolf (1986), Sutton et al. (2000), Whitehead (2002),
Schulze et al. (2003), Rothstein et al. (2006), Kulinskaya et al. (2008), Cooper et al.
(2009), Higgins and Green (2011), Borenstein et al. (2011), Stanley and Doucouliagos
(2012), Pigott (2012), Koricheva et al. (2013).
2.1 Fixed effects model
We are given K studies, each trying to measure some effect θ. The effects can be measured
by a variety of statistics, such as sample means, correlation coefficients and, for studies in
which there are treatment and control arms, difference of sample means, standardized mean
differences, odds ratios, and differences or ratios of binomial probabilities known as risk
differences and relative risks. In the kth study or trial there are nk observations yielding an
estimator θˆk, which is asymptotically normal in the sense that
√
nk (θˆk− θk)→ N(0, vk) in
distribution for some unknown parameters (θk,vk). A second assumption is that for each k a
consistent estimator vˆk of vk exists in the sense that vˆk/vk → 1 in probability. This justifies
large sample confidence intervals for θk of the form θˆk ± z1−α/2{vˆk/nk}1/2, with confidence
coefficient 1 − α. It further follows for the known inverse variance weights wk = nk/vk,
that a large sample confidence interval for the combined or meta effect θw =
∑
k wkθk/W ,
where W =
∑
k wk, is given by θˆw ± zW−1/2.
For the fixed effects model (FEM) it is assumed all θk = θ, say. It is widely recognized
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that this assumption is an over-simplification of reality, but nevertheless an analysis for
it is usually given for the sake of comparison with a random effects model analysis, to be
discussed shortly. For the FEM, θw = θ for any set of weights. The weights that minimize
the standard error of θˆw for estimating θ are the inverse variance weights wk = nk/vk. So
the ‘conventional’ meta-analysis now estimates θ by θˆwˆ =
∑
k wˆkθˆk/Wˆ , where wˆk is the
consistent estimator of wk in the kth study. Figure 1 is an example of a meta-analysis
of seven two-armed binomial studies. The effect is the difference of the two probabilities.
The data is from Fleiss (1993) and concerns the use of aspirin to prevent death following
a myocardial infarction. The plot is a common technique for visualizing the results of a
meta-analysis.
The variance of θˆwˆ is no longer W
−1, because the weights are estimated. In fact, W−1
underestimates this variance (Li et al., 1994; Rukhin, 2009), so that the coverage of the
conventional interval θˆwˆ ± z1−α/2Wˆ−1/2 is lower than the nominal level 1 − α, and the
conventional Wald test, Wˆ 1/2θˆwˆ, for H0 : θw = 0 is too liberal. For example, for normally
distributed data with ni = 3 for each study, the variance of θˆwˆ is K times larger than W
−1
(Rukhin, 2009)!
Another shortcoming of the variance estimation by W−1 is its over-sensitivity to the
minimum of the estimates of the variances in the K studies, which follows from the in-
equality W−1 ≤ min(vk, k = 1, · · · , K) (Li et al., 1994).
An approximate unbiased variance of θˆwˆ up to any order was obtained for the normal
model by Sinha (1985). There are no similar results in the general case.
The maximum likelihood estimator (MLE) of θ does not have a closed form, although
it is a weighted means statistic with the weights inversely proportional to the MLEs of
the within-study variances. Several tests for the common mean, including a test based on
the first-order approximate variance by Sinha (1985) and on the MLE combined with a
parametric bootstrap procedure were studied by simulation in Chang and Pal (2008) for
K = 2 and K = 5. Both tests performed well, with the MLE based test being somewhat
more powerful.
It can be seen that proper statistical inference under the FEM is difficult even under
normality; it becomes even more so in the general case. The problem is exacerbated by
possible correlations between the effects and the weights. Higher order inference needs to
be developed for many non-normal effects used in meta-analysis.
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Figure 1: A forest plot of seven studies involving two binomial arms. For each trial, the summary
of the data and the confidence interval for the difference of the probabilities is shown. The first five
studies are too small to show a significant effect. The bigger studies give contradictory outcomes.
The final meta interval based on the FEM is to a large extend determined by the largest study.
2.2 Random effects model
For the random effects model (REM) it is assumed that the θ1, . . . , θK are a random sample
from a N(θ, τ 2) distribution, with both parameters unknown. When combined with the
assumption that θˆk|θk ∼ N(θk, vk/nk), this leads to the unconditional distribution for the
estimated effect θˆ∗k ∼ N(θ, τ 2+vk/nk). Note that we have changed notation from θˆk to θˆ∗k to
reflect the change in distribution. There are now K + 2 unknown parameters: the overall
or representative effect θ, the inter-study variance τ 2, and the unknown vk, k = 1, . . . , K.
There are two important issues here, how to interpret θ, and how to estimate it. The
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main advantage of the REM over the FEM is that because the effects themselves are a
random sample with mean θ, an estimate of the latter could provide insight into the larger
family of studies which might be carried out under similar conditions. At its most extreme
interpretation, there is an urn of possible studies, and the ones that have been selected
have randomly chosen sample sizes and within-study variances as well as effects, see Shuster
(2010); Buonaccorsi (2006). The choice of the random urn model greatly affects statistical
inference under REM. The conventional estimator θˆ∗wˆ is biased, and the unweighted mean
is recommended in Shuster (2010). However, a more modest interpretation is that the
REM is chosen for mathematical convenience, and allowing for only one more (nuisance)
parameter τ 2. An alternative, multiplicative model for REM based on overdispersion due
to within-studies correlations was recently proposed by Kulinskaya and Olkin (2013). The
real advantage of detecting a positive τ 2 is that it suggests finding explanatory variables (or
moderators) which explain the variation between study outcomes, as in meta-regression,
see Section 2.5. For a recent review of various issues involving the REM, the reader is
referred to Higgins et al. (2009). See also Sutton and Higgins (2008) for a more general
discussion of a variety of meta-analytic methods.
Statistical methods for the REM just described has been the subject of much research
(see Section 2.4.), especially with regard to the nefarious τ 2. This parameter cannot be
estimated to any reasonable precision without a large number K of studies, and hence
neither can θ. The traditional approach of substituting an estimator τˆ 2 for τ 2 into the
asymptotic variance formula Var[θˆ∗k] = τ
2 + vk/nk and applying the estimated inverse vari-
ance weights combination suffers from all the problems of this methodology for the FEM,
further aggravated by neglecting the variability of τˆ 2. It has been applied to thousands
of data sets, despite the lack of theoretical or simulation studies to confirm when it does
work, if ever.
If a prior distribution for θ and τ 2 is chosen, the REM becomes a Bayesian hierarchical
model. Much has recently been written about Bayesian methods in statistical modelling
and meta-analysis is a popular area of application. A very readable introduction to the
methods can be found in Koricheva et al. (2013). Bayesian methods are particularly popular
when performing network meta-analyses, in which studies comparing several treatments
are combined. Both direct comparisons between two treatments used together in a trial as
well as indirect comparisons of the two treatments used in different studies are combined.
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Xie et al. (2011) propose a frequentist method that relies on summarizing the results of
the meta-analysis in the form of a confidence distribution. This is related to the Bayesian
approach using non-informative priors.
2.3 Testing for homogeneity
In a meta-analysis it is usual to conduct a homogeneity test to determine if the effects
measured by the included studies are sufficiently similar. For the FEM, the homogeneity
test is a test of the hypothesis that the underlying effects are all equal, θk = θ. For the
REM, this is the test of the null hypothesis H0 : τ
2 = 0.
The most commonly used test statistic is Cochran’s Q (Cochran, 1937) which is defined
by Q =
∑
k wˆk(θˆk − θˆwˆ)2 with the inverse variance weights wˆk. Several other tests were
compared by Takkouche et al. (1999) and Viechtbauer (2007), but it was concluded that
Q is the best choice. A number of results have been published about the distribution
of Q for the case in which the effects are normally distributed sample means and the
weights are inverses of sample variances. Under these normality assumptions, the chi-
square distribution is an exact distribution of the Q statistic if the variances are assumed
to be known, resulting in known weights. We denote this statistic with known weights by
Qw, to distinguish it from Q = Qwˆ. Since the randomness of the weights is traditionally
ignored in meta analysis, a number of publications provided further distributional results
for Qw, among them Biggerstaff and Tweedie (1997), Jackson (2006), Biggerstaff and
Jackson (2008).
For estimated weights, there is no exact analytic expression for the distribution of
Q, and so an approximation must be used in order to conduct the homogeneity test.
Further, the distribution of Q will vary depending on the effect measures. The chi-square
distribution is asymptotically valid as the sizes nk of the studies become large, but the
approximation is less accurate for small and medium sample sizes, see the simulation studies
by Hedges and Olkin (1985), Viechtbauer (2007) and the references therein. James (1951)
and Welch (1951) proposed separate order O(1/nk) corrections to the null distribution of Q
for the normal case. Welch’s proposal (more commonly used and known as the Welch test)
refers Q to a rescaled F -distribution (cFI−1,ν) with I − 1 and ν degrees of freedom where
ν and c are estimated from the data. Kulinskaya et al. (2003) dealt with the improved
approximation under alternatives for the FEM.
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Kulinskaya et al. (2011b,a) found O(1/N) improvements to the chi-square approxi-
mation to the null distribution for Q applicable to non-normal effect measures, where
N =
∑
k nk is the total sample size. Kulinskaya et al. (2011b) dealt with the situation in
which both the effect and the weight from an individual study depend on a single parame-
ter, with principal application to the standardized mean difference between treatment and
control arms of a study. Kulinskaya et al. (2011a) provides expansions for the first two mo-
ments of Q when the effect and weight for an individual study depends on two parameters,
the effect θk and a nuisance parameter ζk. These expansions were applied to the difference
of binomial probabilities (risks) from treatment and control arms of the studies. In this
context, a two-moment gamma approximation was recommended as an approximate null
distribution of Q. The resulting homogeneity test is substantially more accurate than the
standard chi-square test, especially when the sample sizes are small or moderate.
An asymptotic distribution of Qw for non-normal effects when the sample sizes are
finite and K → ∞ is discussed in Demidenko (2004, Section 5.1.3). This distribution is
asymptotically N(K, (κ− 1)K), where κ is the kurtosis of the underlying distribution.
Asymptotics in the case of K →∞ is discussed by Akritas and Papadatos (2004) both
for Q and for a new unweighted statistic TK which can be used with small sample sizes.
They do not require normality, but some standard moment conditions, and demonstrate
that an asymptotic approximation to the distribution of Q is possible only if the within-
study sizes nk → ∞ suitably fast in relation to K. In that case Qwˆ is asymptotically
equivalent to Qw and K
−1/2(Qwˆ − (K − 1)) ∼ N(0, 2) under the null. They also show that
Q is very unstable for small sample sizes. The unweighted statistic proposed by Akritas
and Papadatos (2004) is given by
TK = K
−1/2
K∑
k=1
[
nk(X¯k. − X¯..)2 − (1− nk
N
)S2k
]
,
where Xki is the i-th observation in the k-th study and S
2
k are sample variances. This
statistic, equivalent to the standard F -statistic in the case of equal study sizes, is yet to be
tried in meta-analytic applications. Akritas and Papadatos (2004) derive its distribution
under local alternatives in FEM. The rates that local alternatives must converge to the
null are K−1/4 for bounded study sizes and K−1/4n−1/2k for nk →∞. These rates resemble
those for lack-of-fit testing in nonparametric regression.
There are so far no results on the distribution of Q or TK for the REM. These results
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would be important for derivation of the distribution of τˆ .
There is no consensus on the appropriateness of conducting a homogeneity test. If the
choice of model in further analysis depends on the Q test as recommended by Normand
(1999) and as is often done in applications, then the two-stage procedure is in use and
the level needs to be adjusted accordingly (Hartung and Knapp, 2003). Another view is
that the heterogeneity should not be tested but quantified by some effect measure (Higgins
et al., 2009), the most popular being the I2 = (Q − (K − 1))/Q proposed by Higgins
and Thompson (2002). I2 is an increasing function of Q, which means that the statistical
properties of I2 can be deduced from those of Q. If there is no additional variance, the
expectation of Q is approximately equal to K − 1 and I2 will be close to zero. If the
alternative is true, Q grows with the total sample size N =
∑
k nk and I
2 tends to 1 as
N →∞, unless the number of studies K grows with N in such a way that the average study
size N/K remains bounded. Appropriately standardized effect measures for heterogeneity
are yet to be derived. The paper by Demidenko et al. (2012) takes a step in this direction.
2.4 Inference for the REM
There are several statistical problems in REM, to do with inference for θ and for τ . Usually,
the former is of primary interest, but the variance of θˆ depends on τ , so the latter cannot
be easily bypassed.
The most popular estimator of τ is the moment estimator of DerSimonian and Laird
(1986)
τ 2DL = max
(
0,
Q− (n− 1)
S1 − S2/S1
)
,
where Q =
∑K
1 wk(θˆk − θ¯)2 is the Q statistic (Cochran, 1937) and Sr =
∑K
1 w
r
i . Instead,
the MLE of τ 2, or the restricted MLE (REML) can be used. Yet another possibility
is to use profile likelihood (Hardy and Thompson, 1996; Malloy et al., 2013). All these
methods require numerical maximization. An easier option is to use the Mandel-Paule
(MP) algorithm (Mandel and Paule, 1970). Given that the weights wk = wk(y) = (y +
vˆk/nk)
−1, the Mandel-Paule estimator is found from the estimating equation
F (y) =
K∑
1
wk(y)(θˆk − θ¯w)2 = K − 1 .
The motivation comes from the fact that, for the true weights, F (y) ∼ χ2K−1 and therefore
the first moment isK−1. The solution is unique because F (y) is the a convex monotonically
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decreasing function of y ≥ 0 (Rukhin, 2009). The MP algorithm was initially introduced in
the context of inter-laboratory studies, but was then adopted for meta-analysis by Rukhin
(2003) and DerSimonian and Kacker (2007). In the modified Mandel-Paule procedure
(MMP) K − 1 is replaced by K in the right-hand side of the above estimating equation.
As was shown in Rukhin and Vangel (1998), under normality, the MLE of τ 2 coincides
with the MMP estimate if the weights wk admit the representation wk = wk(y). The
original MP is similarly related to REML (Rukhin et al., 2000). The MP algorithm is also
a generalized Bayes procedure (Rukhin et al., 2000). Unfortunately, there is no uniformly
MSE optimal estimator of τ 2 over the whole range of τ 2, even if the distribution is normal.
Under normality, improved quadratic estimators of the random variance component τ 2 and
within-study variances σ2k in the spirit of Stein are given in Mathew et al. (2010).
Given an estimate τˆ 2, the weights w∗k = 1/(τˆ
2 + vˆk/nk) can be used to obtain the
combined effect estimate θˆw∗ . Inference for θˆw∗ has the same problems as the inference in
FEM, additionally the variability in τˆ 2 is often neglected. The coverage of the conventional
confidence intervals is considerably below nominal. A further problem with these random
effects confidence intervals is that they can be very sensitive to publication bias. If smaller
studies (with larger variances) are less likely to be published than larger studies (with
smaller variances), then the coverage probabilities of these confidence intervals can rapidly
decrease as the degree of heterogeneity, or the number of studies or both, becomes large
(Henmi and Copas, 2010).
An alternative to the standard inverse weights method accounts for the variability in τ
by replacing the approximating normal distribution for the weighted effect by a Student-t
distribution; theoretical and simulation studies justifying this approach are in Hartung
(1999), Hartung and Makambi (2003), Sidik and Jonkman (2002, 2003, 2006, 2007).
Hardy and Thompson (1996) obtained the ML confidence interval for θ by inverting
the likelihood ratio test for θ combined with the profile likelihood estimate of τ 2. However,
Sørensen (2008) showed that, for small values of K, the distribution of the likelihood ratio
test, and therefore related p-values and confidence intervals, strongly depend on the true
value of τ 2. A higher order asymptotic procedure was recently developed by Sharma and
Mathew (2011), but the regularity conditions for its applicability were not established.
Henmi and Copas (2010) proposed a new interval centered at the FEM combined effect
θˆwˆ and based on the gamma-approximation to the conditional distribution of Q given
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θˆwˆ. The coverages of the intervals by Sidik and Jonkman (2002); Hardy and Thompson
(1996); Sharma and Mathew (2011); Henmi and Copas (2010) are considerably better than
the coverage of conventional intervals for small K (starting from K = 5). Additionally
the interval by Henmi and Copas (2010) is designed to perform well under publication
bias. All these methods assume that normality of estimated effects is already reached and
therefore require considerable within-study sample sizes. As an example, Henmi and Copas
(2010) simulated the odds ratios (their effect size of interest) from the normal distribution,
and therefore have no information on the within-studies sample sizes required for good
coverage. Our experience is that for large K, larger sample sizes are often required for
asymptotic results to hold. Applicability of the above methods to various effect measures
should be explored by extensive simulations. It may be necessary to develop second-order
asymptotic methods for non-normal effect measures such as odds ratios or standardized
mean differences.
A recent addition to this area by Rukhin (2013) proposes new estimators of the between-
study variability which are linear functions of quadratic statistics (Xi−Xj)2 and the sample
variances. This class includes the τ 2DL estimator (DerSimonian and Laird, 1986) among
others. The proposed estimators perform well in the case of small to moderate numbers
of studies. An important conclusion is that different estimators of τ 2 should be used
depending on the inferential task: “one to minimize the variance of the treatment effect
statistic; another to construct a reliable confidence interval for this parameter; yet another
to estimate τ 2 itself! ”
Another approach by Malloy et al. (2013) for random effects having the Student-t distri-
bution uses variance stabilization before finding maximum likelihood and profile estimates
of both θ and τ 2; this approach yields explicit formulae for the standard errors of each
estimator in terms of the number of studies K. In addition, these authors show that the
best performing confidence interval for δ is a simple t-interval which does not require an
estimate of τ 2. Further, both traditional and new methods for the FEM are shown to be
robust to small τ 2 > 0, so that if K is too small to estimate τ 2, a practical solution is to
revert to the FEM, even though one might prefer the REM. These results should be able
to be extended to the standardized mean difference, see Malloy et al. (2013, Section 1.4).
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2.5 Meta-regression
Let θˆk denote the estimated effect for the kth study which is based on nk observations, and
suppose that these estimates satisfy
θˆk = β0 + β
′xk + εk (2.1)
where xk = [xk1, . . . , xkp]
′ is a vector of study covariates, called moderators in the meta-
analytic literature, β = [β1, . . . , βp] is a vector of unknown coefficients, and εk ∼ N(0, vk/nk),
where vk are known constants. This is the fixed effects meta-regression model. Tests for
non-zero coefficients can be found using traditional weighted least squares. Examples are
given in Hedges and Olkin (1993), where variance stabilization of the effect estimates pre-
cedes weighted least squares in order to obtain θˆk’s (at least approximately) satisfying the
normality assumption with known variances. When the variances vk/nk are unknown, it is
tempting to use weighted least squares with estimated variances vˆk/nk, but this can lead to
highly biased estimates of the coefficients, as demonstrated in Malloy et al. (2011), where
it is compared with a generalized linear model approach.
It is unlikely that all moderators would be identified in advance, so that there would
be unknown heterogeneity in studies that should be accounted for. A mixed effects meta-
regression model is then appropriate. The simplest version of this model, the one where
only the intercept is random, was introduced by Colditz et al. (1994); Berkey et al. (1995),
and assumes that
θˆk = β0 + β
′xk + bk + εk , (2.2)
where the bk’s are assumed to be independent of each other, the moderators and of the
εk’s; further they are assumed to be distributed bk ∼ N(0, τ 2), where τ 2 is the unknown
inter-study variance. Berkey et al. (1995) did assume that the vk/nk’s were approximately
equal to within study estimates vˆk/nk , and proceeded to use weighted least squares with
inverse variance weights 1/{τˆ 2 + vˆk/nk}, where τˆ 2 is obtained by an iterative procedure.
Little progress has been made since then in dealing with two outstanding problems, namely
the usually unwarranted assumptions of normality of effect size estimates and of known
within-study variances, see Huizenga et al. (2011) for a thorough discussion.
There are at least two promising avenues for further research in mixed effects meta-
regression. First, maximum likelihood estimation of the parameters β and τ 2 using the
full likelihood, not the conditional one based on a false assumptions of known variances
15
or normality where they are clearly not satisfied. Second, parameter estimation using
generalized linear models after variance stabilization, with the then reasonable assumption
of approximate normality.
2.6 Individual participant data versus summary statistics
Although considered the gold standard, individual participant data (IPD) and the expertise
required for its analysis are rarely both available, and IPD meta analysis is used only in
a small minority of the MAs. 9.5% of the publications between 1990 to 2004 according to
Simmonds et al. (2005).
Aggregated (summary) data (AD) may be a matter of analytic choice or be neces-
sitated by lack of the original data or lack of permission to use it, possibly because of
ethical/confidentiality issues.
For the most common case of studies of a continuous outcome with two arms (treatment
and control), Mathew and Nordstroo¨m (1999) have shown that AD analysis results under
FEM are equivalent to those based on IPD regardless of the covariance structure within
the studies. More recently, the same authors Mathew and Nordstroo¨m (2010) considered
the weighted estimation of a linear function of the mean, based on linear models for sum-
mary data and for IPD. Within-studies covariances were assumed known. They derived a
condition under which the IPD and AD meta-analysis estimators coincide. This condition
always holds for the FEM, and for the REM it holds when the proportion in the treat-
ment arm is the same across studies. They also show that when covariates are present,
the two estimators coincide only under an extra simplifying assumption that represents
homogeneity of the covariates across studies. When the condition is not satisfied, the one-
step analysis is always more efficient. The results by Mathew and Nordstroo¨m (2010) are
not valid when within-trial variances and covariances are not known but estimated from
the data. An example of this is shown in Jones et al. (2009), where the AD meta-analysis
estimates have a very slightly smaller standard error than the IPD meta-analysis estimates.
Lin and Zeng (2010) studied the relative efficiency of AD versus IPD meta-analysis in
the multivariate FEM with general, not necessarily the same, distributions across studies.
They show that, for all commonly used parametric and semi-parametric models, there
is no asymptotic efficiency gain by analyzing the original data if the parameter of main
interest has a common value across studies, the nuisance parameters have distinct values
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among studies, and the summary statistics are based on maximum likelihood. They also
consider the case of estimated within-study covariance matrices, and then the equivalence
holds asymptotically. They also studied the relative efficiency of the two methods when
the parameter of main interest has different values among studies, i.e. under the UFEM
(unequal but fixed effects model), or when there are common nuisance parameters across
studies. Their examples include the linear model, logistic and Cox regression.
Lin and Zeng (2010) comment that one reason for obtaining original data is to model
individual-level covariates. They have shown that there is no bias or efficiency loss if the
effect estimates are properly adjusted for individual-level covariates within each study and
then combined. They also claim that their results hold also for the REM, but these results
are unpublished.
2.7 Meta-analysis of observational studies
Randomized controlled trials (RCTs) are considered the gold standard in medicine and
health sciences, and restriction of meta-analyses to synthesis of their findings is strongly
supported by the influential Cochrane Collaboration (Higgins and Green, 2011). The main
advantage of randomisation of allocation of participants into control and treatment arms
of a study is that the difference between the summary effects in the two arms is an un-
biased estimate of the true effect. Randomization takes care of the various observed and
unobserved prognostic factors given that their differences between the arms are truly ran-
dom. No further statistical modelling is necessary. In real life, randomization may not
be practicable or ethical, and observational studies (experimental or not) constitute the
bulk of the body of evidence in epidemiology, life and social sciences (Stroup et al., 2000;
Konnerup and Kongsted, 2009). Hence a large and fast growing number of meta-analyses
of observation studies. The standards of reporting and main issues in the meta-analysis
of observational studies in epidemiology are summarized in the MOOSE consensus state-
ment, Stroup et al. (2000, for the meta-analysis of observational studies in epidemiology
(MOOSE) group). The authors recommend in-depth investigation of issues to do with
heterogeneity of populations, designs and outcomes across studies, and formal evaluation
of the study quality. Reeves and Wells (2013) is a recent special issue covering the topic
of the use of non-randomized studies in systematic reviews.
The main concern in meta-analysis of observational studies is the existence of various
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biases due to non-random allocation. The main danger is the existence of a systematic
selection bias due to systematic differences between the groups at the baseline (Deeks
et al., 2003). These baseline differences may be related to outcomes; differences in severity
of a condition of interest as the reason for treatment allocation is an example of such
a relationship. This introduces systematic bias leading to over- or under-estimation of
treatment effects. Other biases in non-randomized studies include attrition bias (due to
drop-out or non-compliance), detection bias (because of non-standardized assessment of
outcomes) and performance bias (errors and inconsistencies in the allocation, application
and recording of interventions) (Deeks et al., 2003).
Selection bias can potentially be adjusted for by statistical modelling. This includes
modelling the effects of interest controlling for known prognostic factors, or modelling the
allocation mechanism itself and then using the results for the effect adjustment (propen-
sity score analysis). The empirical modelling performed in Deeks et al. (2003) showed
inadequacy of both approaches; the main reason is the omission of important unknown
confounders.
Due to the high risk of biases and typically large sample sizes in observational stud-
ies, meta-analysis may reach spurious conclusions with very tight confidence intervals
around biased summary effects. Different biases can be modelled explicitly (Wolpert and
Mengersen, 2004), but this requires some strong assumptions about the nature of biases.
An alternative approach is the elicitation of expert opinions on the nature and size of
biases. In a recent paper by Thompson et al. (2011) the biases are separated into inter-
nal biases reflecting the study quality and external biases reflecting generalisability to a
target setting. Next, subjective opinions on the size of biases and their type (additive vs
multiplicative) are elicited from several experts and are used for bias adjustment.
Perhaps a safer option is to consider the robustness of the combined effects to different
levels of bias in point estimates or their variances. An interesting proposal by Salanti and
Ioannidis (2009) is to assume a limit to the chance that an effect is in a particular direction
and not in the other one. They call this the credibility ceiling. For the kth study with the
effect θk and variance vk, consider a random variable u ∼ N(θk, vk). Then the credibility
is defined as P (u < 0|θk > 0) or P (u > 0|θk < 0). If this probability is less than the
credibility limit c, the variance is recalculated as v∗k = max{(θk/zc)2, vk}, where zc is the
percentage point from the standard normal distribution. Meta-analysis is repeated for a
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range of values of c, using these inflated variances. Various issues to do with biases in
meta-analysis are considered in more detail in Section 3.
Finally, it is possible to design an unbiased observational study. Available methods
include matching, natural experiments and the use of instrumental variables; see Konnerup
and Kongsted (2009, Section 4) for more details.
3 Publication and other biases
As mentioned in the introduction, bias is the most immediate danger when combining the
estimated effects from K trials or studies. In this section we touch on two sources of such
bias. First, the selection bias resulting from the inability of accessing studies with negative
outcomes and, second, the effect of small sample biases on a meta-analysis.
3.1 Publication bias
Publication bias refers to the case in which the K studies we are given access to for our
meta-analysis are those with a relatively large estimated effect. Other studies, with smaller
effects may, however, also exist. This is a special case of selection bias. We are handed K
estimated effects and want to combine them to produce an overall estimate. If the large
estimated effects are over-sampled, then the naive, uncorrected combination overestimates
the true effect.
Example 3.1. For a formal discussion of this bias, we will consider the case, where the
effect estimates in each trial are variance stabilized. To distinguish these estimates from the
more general statistics θˆk, we denote them by κˆk and assume that they have variance equal
to 1/nk, that is, the test statistic
√
nkκˆk has constant variance 1. With a fixed common
effect κ we then have approximately κˆk ∼ N(κ, 1/nk). The combined estimated effect from
K randomly selected studies is κˆmeta =
∑K
k=1 nkκˆk/N ∼ N(κ, 1/N), where N =
∑K
k=1 nk is
the total sample size. This represents the ideal situation, where the meta-analysis produces
an estimated effect which is equal to what one would get if all the data were combined
and a single trial of size N were performed. Since the weights depend on the known nk,
variance stabilization leads to more interpretable and more stable meta-analysis procedures
when compared to the usual fixed common effects estimates. For details, see Kulinskaya
et al. (2008).
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If only the studies which reach a minimal level of significance are entered into the meta-
analysis, we no longer get to work with a random sample of K studies and a selection bias is
created. Because those studies resulting in insignificant effects are filed away and forgotten,
selection based on significance is sometimes referred to as the file drawer effect.
A well-written account of selection bias and its consequences can be found in an article
by J. Lehrer that appeared in the New Yorker magazine (Lehrer, 2010). He points out
that selection bias, if ignored, can have costly consequences both in terms of ill-advised
research activity and in practical terms, by influencing, for example, medical decision
making. Selection bias occurs not only because the results contained in a submitted article
are negative, but also due to the reviewers likes and dislikes, the withholding of data for
commercial purposes, the choice of design of the clinical trial, and so on. Completely
different sources of bias exist as well. As mentioned by Lehrer, researchers themselves
may be prone to reach firmer conclusions than warranted due to preconceived notions and
subtle biases.
3.1.1 Assessing publication bias
If the number of studies K entering a meta-analysis is large, there is a reasonable hope
in determining whether a selection as described in the above example has occured and
possibly even in estimating the number of missing studies.
Example 3.2. We continue with the example above in order to determine the consequences
of selecting only certain studies. Suppose that the true (fixed) effect is κ and that the null
hypothesis being tested is κ0. If only the studies which reach significance are selected, only
the studies with
√
nk(κˆk − κ0) > b = z1−α are included in the meta-analysis. In our model,
√
nkκˆk ∼ N(√nkκ, 1), which implies that the probability for a study of size n to pass the
selection is 1 − Φ(b + √n(κ0 − κ)). This does not depend on n if κ0 = κ, that is, the
null hypothesis being tested is true. The selection favors small studies if κ0 > κ and large
studies otherwise. Being selected means that
√
nkκˆk has a truncated normal density equal
to
f(x) =
ϕ(x−√nkκ)
1− Φ(b+√nk(κ0 − κ)) for x > b+
√
nkκ0 ,
where Φ, ϕ denote the standard normal distribution and density, respectively.
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If a non-random selection has produced the studies available in a meta-analysis, similar
to the above example, then for large K the histogram of the standardized effect estimates
or of the raw effect estimates would show the missing parts. If K is small, the task of
assessing missingness is essentially impossible, unless additional information is provided
through other means, for example if all the studies had to be announced via a database.
To make informal inferences about missingness, the funnel plot is popular. This graph-
ical display was introduced in Light and Pillemer (1984) and has been reviewed in Egger
et al. (1997). The funnel plot replaces the histograms mentioned above and brings into
consideration also the trial sizes or the precision of the effect estimates. For K studies with
effect estimates κˆk and sizes nk, one could produce
• either a scatter plot of nk vs. κˆk for k = 1, . . . , K,
• or a scatter plot of −1/√nk vs. κˆk for k = 1, . . . , K, or
• or a scatter plot of −√vˆk vs. κˆk for k = 1, . . . , K, with −vˆk being the estimated
variance of κˆk.
If the studies are randomly selected, the point scatter will exhibit a funnel shape, with the
large studies tightly clustered around the common effect and the smaller studies showing
more variation. Publication bias as discussed in the example will lead to holes or asymmetry
in the funnel plot. Duval and Tweedie (2000b) and Duval and Tweedie (2000a) describe a
relatively simple and intuitive method based on the expected symmetry of the funnel plot
for estimating the number of missing studies and for creating imputed estimated effects
and standard errors for the missing studies. Their method is based on the idea that the
missing studies are missing because the effects found in the studies were too small.
Of course, the asymmetry in the point cloud of a funnel plot can have other causes. If,
for example, a single large study has been performed and it contradicts a host of previous
smaller studies, the funnel plot can take on an unexpected shape.
3.1.2 Correcting the bias
In order to estimate the bias caused by selection bias, various models can be used. The
statistical literature on estimation based on samples subject to selection bias focuses on
procedures like the EM-algorithm or data augmentation, censoring and truncation as well
as various biasing mechanisms. An example of a fairly general estimation aim and a fairly
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general selection mechanism is Vardi (1985). An example that is more specific to meta-
analysis is Givens et al. (1997).
Example 3.3. This example is again based on normally distributed variance stabilized
effect estimates with variance 1/nk. To make the calculations easier, suppose that the true
value of the fixed effect is κ = 0 and that the null hypothesis being tested is also κ0 = 0,
so that the null hypothesis being tested is true. Suppose further, that only studies with
√
nkκˆk > b are included in the meta-analysis. In our model,
√
nkκˆk ∼ N(0, 1), which
implies that a fixed fraction of all studies will be selected and that this fraction is equal to
1− Φ(b). The combined effect κˆmeta =
∑K
k=1 nkκˆk/N based on K such studies, is not any
longer distributed as N(κ, 1/N). Being selected means that √nkκˆk has a truncated normal
density
f(x) =
ϕ(x)∫∞
b
ϕ(u) du
=
ϕ(x)
1− Φ(b) .
An elementary calculation shows that the expectation and variance of any selected
√
nkκˆk
are 0 < µ(b) = ϕ(b)/(1 − Φ(b)) and σ2(b) = 1 − µ(b)(µ(b) − b) < 1. For the com-
bined effect κˆmeta, this implies an expectation of 0 <
∑K
k=1
√
nkµ(b)/N and a variance of
σ2(b)/N < 1/N . Were we to ignore the bias, we would often observe a significant effect,
because in order to compute a p-value, we would compare the combined value
√
Nκˆmeta
with a standard normal distribution. In reality, though, the mean of this random variable
is equal to µ(b)
∑K
k=1
√
nkµ(b)/
√∑K
k=1 nk ≥ µ(b)
√
K, where the inequality follows from
the concavity of the square root. As the number of studies grows and if b is not too small,
it becomes very likely that the combined effect is judged to be significantly different from
κ = 0 and one would falsely declare the discovery of a significant positive effect.
If the selection of available studies is not based on significance, but rather on the observed
raw effect, then the chance of being included in the meta-analysis depends on the sample
size. Suppose only those studies with κˆk > b are selected. Under our model, the probability
of selection is then equal to P[κˆk > b] = 1 − Φ(√nkb), which means that the selection
of a trial for inclusion in a meta-analysis is correlated with the trial size. If b > 0,
large studies are often selected out and do not make it into a meta-analysis, while for
b < 0 all the studies have a good chance of being selected. This type of selection bias
leads to more complex properties of κˆmeta than in the previous case. Given that a trial
of size nk has passed selection, the cumulative distribution of κˆk is Fk(x) = (Φ(
√
nkx) −
Φ(
√
nkb))/(1−Φ(√nkb)) which has density fk(x) = ϕ(√nkx)√nk/(1−Φ(√nkb)). It follows
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that E[κˆk] = (
√
nkϕ(
√
nkb)/[(1− Φ(√nkb))] ≈ b, where the approximation holds for b > 0
and large nk and follows from the asymptotic equivalence 1 − Φ(x) ∼ ϕ(x)/x as x → ∞.
The expected value of κˆmeta cannot be computed without more knowledge about the choice
of nk.
Shuster (2010) has put forward the idea that the correlation between sample size and
effect size is a common phenomenon in meta-analysis. Any weighted estimate using weights
that depend on the sample size then causes a bias. However, in the absence of selection
bias, the arithmetic mean of the trial effects, κˆmeta =
∑K
k=1 κˆk/K, remains an unbiased
and, in this sense, viable estimate.
If an effect estimate κˆ is included in a meta-analysis only if
√
nκˆ > b, one can model the
√
nkκˆk included in the analysis as a left-censored sample with a fixed censoring bound b.
By stipulating values for the number of censored studies, M , the bound, b, and the sample
sizes of the missing studies n and then investigating what biasing effect such a scenario
would have on the meta-analysis, we could gain a better understanding of the bias. This is
easy to make precise in the case of variance stabilized effect estimates with (approximate)
normal distribution. In this case, we have κˆk ∼ N(κ, 1/nk), where κ is the fixed common
effect.
Suppose K studies are available for a meta-analysis and M studies are missing (or
rather censored!) and suppose that the selection is based on significance when testing
H0 : κ = κ0, which means that a trial is censored when (κˆ − κ0)
√
n ≤ b, that is, when
κˆ ≤ b/√n+ κ0. The likelihood function for the unknown common effect κ is then equal to
L(κ) =
K∏
k=1
ϕ ((κˆk − κ)√nk)
M∏
m=1
Φ (b−√nm(κ− κ0)) . (3.1)
In order to compute this likelihood, we thus need to know not only M and the censoring
mechanism (that is, b), but also the trial sizes of the missing studies n1, . . . , nM . The
log-likelihood is
log(L(κ)) = `(κ) = −(K/2) log(2pi)−
K∑
k=1
− nk
2
(κˆk−κ)2 +
M∑
m=1
log (Φ (b−√nm(κ− κ0))) .
(3.2)
The last term in this log-likelihood is due to the missing studies and its derivative,∑M
m=1 −
(√
nmϕ(b−√nm(κ−κ0))
Φ(b−√nm(κ−κ0))
)
, is everywhere negative, that is, the term is decreasing in κ.
When κ → ∞, the derivative tends to −∞ and behaves asymptotically linear in κ, while
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for small values of κ, it quickly approaches zero, because the numerator dominates. Its
second derivative,
−
M∑
m=1
[
nmϕ
(
b−√nm(κ− κ0)
)
Φ
(
b−√nm(κ− κ0)
) (b−√nm(κ− κ0) + ϕ (b−√nm(κ− κ0))
Φ
(
b−√nm(κ− κ0)
))] ,
is negative, which shows that this term is strictly concave in κ. The first two terms in
log(L(κ)) form the usual normal log-likelihood, a strictly concave quadratic polynomial in
κ, whose maximum is at κˆmeta =
∑K
k=1 nkκˆk/N and whose second derivative is −
∑K
k=1 nk.
Substituting the sum of maximum likelihood estimator of κ in the formula for the second
derivative of the log-likelihood and taking the negative inverse of this value, allows us to
estimate the variance of the maximum likelihood estimate.
The censored log-likelihood (3.2) is a well-behaved, strictly concave function with a
unique maximum. Since it is the sum of a concave quadratic with a function close to zero
for small values of κ and quickly tending to −∞ for large values, the quadratic first part
is modified as shown in Figure 2.
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Figure 2: The log-likelihood based on a single study with κˆ = 0.33 and n = 40 is shown. The dotted
line shows the log-likelihood when adding a missing study of size n = 30, with hypothesized value
κ0 = 0 and cutoff b = z0.95 = 1.645. The effect of adding the censored part makes large values of κ
much less likely, whereas the small values are left untouched. As a result, the maximum likelihood
of the censored log-likelihood moves towards smaller κ values. The maximum likelihood estimate
of κ based on the censored likelihood becomes 0.245 with an estimated variance of roughly 1/57.
The p-value before inclusion of the censored study is 0.018 and becomes 0.031 upon inclusion of
the missing study.
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Since the log-likelihood (3.2) is a nice concave function, it is easy to determine the
maximum likelihood estimator through the use of the Newton-Raphson algorithm (see
Kulinskaya et al. (2008), Chapter 26), with a starting value equal to the meta effect esti-
mated with the observed studies.
With regard to the number of missing studies, several values should probably be tried.
If one believes that the significance of the published studies is entirely due to chance, one
might be inclined to add the 95% missing studies to the 5% published ones as in Rosenthal
(1979). In the above example, this would mean that 19 missing studies existed. If we add
these 19 studies with smallish sample sizes of 10 for each, the combined effect is estimated
to be 0.08 with a p-value of 0.21. If we take the 19 studies to be small screening studies of
size n = 2 each, the effect estimate remains quite high (0.21) but is also insignificant (p-
value of 0.067). This illustrates the difficulties one faces and which are unavoidable. One
has to make quite strong assumptions about the selection mechanism and one has to guess
or estimate the number and sample sizes of the missing studies. The statistical analysis we
outlined above does not take into account the uncertainty inherent in these choices. All
it can do is to tell us under what assumptions the resulting meta effect estimate becomes
insignificant.
3.2 Small Sample Biases
The deleterious effect on coverage probability of centering a confidence interval on a biased
estimator of the parameter seems to be relatively unknown and is widely ignored in the
traditional approach to meta-analysis. We illustrate by a simple example how this bias
undermines the coverage probabilities of fixed common effects as the number of studies
increases from 1 to 5.
Comparison of four confidence intervals for p based on binomial observations
Confidence intervals for the binomial parameter p have long been of interest to statisticians,
see the discussion paper Brown et al. (2001) and literature referred to therein. Amongst
the best performers are the Wilson interval (Wilson, 1927), and a similar, but simpler to
explain interval by Agresti and Coull (1998). The latter (with c = 2) falls in the class of
intervals centered on p˜c = (X + c)/(n+ 2c), where X has a binomial B(n, p) distribution.
These estimators are studied by Bo¨hning and Viwatwongkasen (2005). It is easy to see
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that p˜c is for all c > 0 biased towards 1/2 and satisfies E[p˜c] = p+ c(1− 2p)/(n+ 2c) and
Var[p˜c] = np(1− p)/(n+ 2c)2.
Agresti and Coull (1998) suggest the interval p˜2 ± z0.975
√
p˜2(1− p˜2)/(n+ 4) , which is
slightly more conservative than the one obtained using the standard error of p˜2. This is
the first of the four intervals we study and we denote it IAC. Amongst the intervals of the
form p˜c ± z0.975
√
np˜c(1− p˜c) /(n+ 2c), Bo¨hning and Viwatwongkasen (2005) recommends
the use of c = 1 for a number of reasons, so this is the second interval IBV we will include
in our comparison.
The third interval IAS to be considered is the traditional arcsine interval which is ob-
tained in two steps: first p˜c is transformed to h(p˜c) = 2arcsin(
√
p˜c ), which is asymptotically
normal with mean h(p) and variance 1/n. This yields the approximate 95% confidence in-
terval h(p˜c)±z0.975/
√
n for h(p). This interval, call it [l, u], is truncated to lie within [0, pi],
the range of h(p) for p ∈ [0, 1], and then back-transformed via h−1([l, u]) = sin([l, u]/2)
to an interval of the same coverage for p. While Anscombe (1948) found that c = 3/8
provided the best variance stabilization, here we use c = 1/2, which yields similar results.
The above three intervals are biased towards 1/2. We now give a bias correction for
the arcsine interval. By expanding h(p˜c) about h(p) in a Taylor series and taking the
expectation, one finds the bias in h(p˜c) for estimating h(p) to be
E[h(p˜c)− h(p)] .= {h
′(p)}3(1− 2p)
4(n+ 2c)2
[
a0c
2 + a1c+ a2
]
,
where a0 = 12p(1− p)− 1, a1 = 4p(1− p) and a2 = −np(1− p). The quadratic in brackets
is 0 when c = 1/4 +O(1/n), for p bounded away from 0 and 1. The fourth interval in our
study is the arcsine interval based on h(p˜c), where c = 1/4. We call this interval IASBC. We
note that Bo¨hning and Viwatwongkasen (2005, Theorem 4.1) found that c = 1/4 minimizes
the average bias in p˜c(1− p˜c) for estimating p(1− p).
3.2.1 Simulation study comparing the four estimators
In Figure 3 are shown the results of 10,000 simulations of X ∼ B(20, p) at increments
of 0.01. The upper left plot gives the estimated bias for p˜2 (solid line) and the bias in
p˜1 (dashed line) for estimating p. These graphs are linear in p; they correspond to the
biases in the centers of the AC interval and the BV interval, respectively. Also shown are
the biases of h(p˜0.5) (dot-dashed line) and h(p˜0.25) (dotted line) for estimating h(p); they
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correspond to centers of the arcsine and bias-corrected arcsine intervals for estimating h(p).
Note that the bias-correction works quite well for all p except near the boundaries.
The top right plot in Figure 3 shows the empirical standard deviation of each of the
four estimators, when divided by its estimated standard deviation. For example, the solid
line depicts the graph of√
V̂ar
(
p˜2/
√
p˜2(1− p˜2)/(n+ 4)
)
versus p ,
where V̂ar is the estimate based on the simulation. This would be close to 1 if the standard
deviation were known. However, this plot shows that this ratio is far from 1, and the
situation does not improve with increasing n, as other simulations, not shown, demonstrate.
Similar remarks apply to the standardized p˜1 shown in the dashed line. The standardized
version of h(p˜0.5), namely
√
nh(p˜0.5) in the dot-dashed line has empirical standard deviation
near 1, as one would expect from a variance stabilized statistic. Somewhat surprisingly, the
bias-corrected version
√
nh(p˜0.25) in the dotted line reveals an empirical standard deviation
even closer to 1 over the range of p.
The left-hand plot in the second row of Figure 3 shows the empirical coverages of the 4
intervals, again as a function of p. Note that neither the BV or the bias-corrected arcsine
interval provides adequate coverage over the range of p. However, the AC interval and the
arcsine interval have coverage between 94% and 97% for most values of p.
What are the implications for meta-analysis? We illustrate the phenomenon of how
persistent bias undermines coverage probabilities in the bottom right plot of Figure 3,
where the intervals are based on K = 5 studies, each of size n = 20. The AC and BV
intervals are centered on the weighted average of the 5 individual estimates of p, namely
p˜c,w =
∑
w˜kp˜c,k/(
∑
w˜k), where w˜k is the estimated inverse variance of p˜c,k. To obtain the
meta-interval of nominal coverage 95%, one takes p˜c,w ± z0.975/(
∑
w˜k)
1/2.
The arcsine interval [LAS, UAS] for h(p) is obtained by finding the weighted average∑
k nkh(p˜ 0.5,k)/(
∑
k nk) and adding and subtracting z0.975/(
∑
k nk)
1/2. This is then back-
transformed to an interval for p via h−1([LAS, UAS]). The bias-corrected version is found in
the same way, starting with the bias-corrected estimators p˜0.25, k, k = 1, . . . , 5.
The results are plain to see in the bottom-right hand plot of Figure 3. The estimated
inverse weights coverage probabilities are now unacceptably low, even though these inter-
vals are based on more information than the bottom-left hand plot which is based on a
single study. Of course the AC and BV intervals were not designed for meta-analysis, but
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they were used here to illustrate the point that what works well for one study, will not nec-
essarily work at all in a meta-analysis using estimated inverse variance weights, especially
if the center of the interval is biased for the parameter of interest. The plots in Figure 3
are typical of what we found for many more choices of sample sizes n1, . . . , nK for this fixed
effects model. Increasing the study sample sizes does not remove the problem; bias will
cause significant loss of coverage with K only 5 or 10 and the situation deteriorates with
increasing K. On the other hand, the bias-corrected arcsine interval maintains its good
coverage for a large number of studies, even K = 100.
4 Multivariate meta-analysis and meta-regression
Development of multivariate methods is necessitated by an abundance of studies report-
ing a number of correlated outcomes which are habitually meta-analyzed independently
using univariate methods. Multiple outcomes appear by design in such areas as diagnostic
test meta-analysis and network meta-analysis. The former usually models sensitivity and
specificity of diagnostic tests requiring bivariate analysis, see van Houwelingen et al. (1993);
Harbord et al. (2007); Putter et al. (2010); Paul et al. (2010). The latter aims to compare
multiple treatments, see the recent reviews Jansen et al. (2011); Hoaglin et al. (2011) for
more details. Multiple outcomes, such as disease-free and all-cause survival, also appear
routinely in both clinical trials and observational studies. See Jackson et al. (2011) and its
discussion for comprehensive reviews.
The potential applications of multivariate analysis are found in the collection Arends
(2006), which summarizes most of the material in Arends et al. (2000); van Houwelingen
et al. (2002); Arends et al. (2003, 008a,b). These papers lead the way in demonstrating
what one could do if normality of effects sizes with known variances is assumed. But
there are neither sensitivity analyses nor mathematical arguments nor simulation studies
to support the models. Applications include comparing relative risks of treatment and
control arms, comparing ROC curves, comparing risks with baseline risks, and comparison
of survival curves. A recent detailed review of Arends (2006) is given in Staudte (2010).
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4.1 Multivariate meta-analysis
For the multivariate random effects model it is assumed that vectors of estimates
yk = µ+ bk + k, k = 1, · · · , K,
where now µ, bk and k are p-vectors, and bk and k have zero means and covariance
matrices Σb and Σk. Usually bk and k are assumed to be independent and multivariate
normal. These terms have the same interpretation as in the univariate REM. In the normal
case, marginally
yk ∼ N(µ,Σb + Σk),
where vectors of estimates yk are further assumed to be independent because they come
from different studies. Exactly as in the univariate meta-analysis, the within-study vari-
ances Σk are assumed to be known, and the goal is to estimate µ and Σb. When not all
outcomes are observed in all studies, a slightly more general model has Cov(bk) = V k =
HkΩH
′
k for design matrices Hk. Here Ω is called the heterogeneity matrix by Demidenko
(2004, Section 5.3.1). For simplicity, we shall assume that all studies provide all effects.
The pooled estimate of µ is given by a familiar weighted mean
µˆ =
( K∑
k=1
(Σk + Σb)
−1)−1( K∑
k=1
(Σk + Σb)
−1Y k
)
.
The standard approach to inference about the effects substitutes estimated Σ̂b instead
of true between-studies variance. Then the variance of µˆ is given by
Var(µˆ) =
( K∑
k=1
(Σk + Σ̂b)
−1)−1 .
How large should be the number of studies K and the within studies sample sizes for this
to work is not known. This covariance matrix can be used to provide further inference
such as univariate and joint confidence regions.
Statistical issues related to the actual randomness of the estimated within-studies co-
variance matrices Σk have not yet been addressed in the multivariate meta-analysis. Esti-
mation of Σ̂b can be achieved by maximum likelihood, REML, profile likelihood, and the
method of moments (unweighted or weighted) (Jackson et al., 2011). Chen et al. (2012)
developed a noniterative method of moments matrix estimator for the between-study co-
variance matrix. This estimator is a multivariate extension of DerSimonian and Laird’s
29
univariate method of moments estimator, and it is invariant to linear transformations.
Attention should be given to the constraint that this matrix should be positive-definite.
The simplest way to achieve this is to use a projection of Σ̂b on the set of nonnegative
definite matrices found by Σ˜b = PΛ+P
′, where P is the matrix of eigenvectors and Λ+
is the matrix of truncated at 0 eigenvalues of matrix Σ̂b, Demidenko (2004, Section 5.3.3).
To relax the assumption of normality, many of these methods can be cast in an unbiased
estimating equations (EE) format (Ritz et al., 2008). These EE methods are asymptoti-
cally (K →∞) equivalent to ML for distributions with zero third moment, and are much
simpler computationally. Bayesian methods are available but they may be particularly
sensitive to the choice of prior with the increase in the dimensionality, see Jackson et al.
(2011) for discussion. Rukhin (2007) investigated the multivariate REM under normality.
He does not consider within-study covariance matrices Σk known; under normality their
sample counterparts have the scaled Wishart distribution. He discussed ML and REML
estimation, but the main focus of his paper is the generalization of DerSimonian-Laird
and Mandel-Paule techniques to the multivariate setting, see also Jackson et al. (2010).
Similar to the univariate case, the Mandel-Paule estimator is close to the REML estimator.
Rukhin (2007) also provides two residuals-based estimators of the covariance matrix of the
weighted mean µˆ. He showed that, for a general matrix of weights, an unbiased quadratic
estimator of Var(µˆ) does not exist, and derived an almost unbiased estimator which is
considerably better than the standard inverted sum of weights.
4.2 Multivariate meta-regression
Multivariate meta regression further considers µˆ = Xβ where X = (X1, X2, · · · , Xk)′ is
an n×p design matrix, and β is a p×1 vector of regression coefficients. This problem is very
similar and requires the same techniques. For any weight matrix W = diag(W1, · · · ,Wk)
and a covariance matrix S = diag(S1, · · · , Sk), the weighted least-squares estimator of β
is
bW =
( K∑
k=1
X ′kWkXk
)−1( K∑
k=1
XkWkYk
)
.
The covariance matrix of b is
Cov(bW ) =
( K∑
k=1
X ′kWkXk
)−1( K∑
k=1
XkWkSkWkXk
)( K∑
k=1
X ′kWkXk
)−1
.
The main difficulty in the multivariate meta-analysis and meta-regression is the lack
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of knowledge of the within-study correlations. These correlations are not reported in the
underlying studies. Thus the matrices Σk are not known beyond the estimated main
diagonals, unless the full within-studies data are available. Correlations can be calculated
analytically for mutually exclusive binary outcomes from a multinomial distribution, such
as death from different causes (Trikalinos and Olkin, 2008), but this is not possible in
general. One possibility is to make some assumptions about the within-study correlations,
the simplest being the constant within-study correlation ρ. In this vein, Riley et al. (2008)
proposes to replace the marginal covariance matrix Σb + Σk by a matrix with constant
correlation instead of separate within- and between-studies correlations. This approach
was used only in a bivariate setting, and its generalizability is not clear.
A recent paper (Hedges et al., 2010) proposed to estimate the covariance matrix Cov(bW )
of a weighted estimator in a meta-regression context by substituting empirical within-study
covariance matrices eke
′
k, i.e. the matrices of weighted cross-products of within-study
residuals ek = Yk −Xkb for Sk in the above equation. Thus, the covariance is estimated
by
V̂ =
( K∑
k=1
X ′kWkXk
)−1( K∑
k=1
XkWkeke
′
kWkXk
)( K∑
k=1
X ′kWkXk
)−1
.
For a sequence of independent random matrices Xk, Wk, k, with diagonal matrices of
weights Wk, when K →∞ Hedges et al. (2010) showed that under some regularity condi-
tions b is approximately Np(β,V ). These conditions include uniform boundedness of the
weights, the error variances and various covariances, and some moment conditions. Further
Hedges et al. (2010) propose taking equal (inverse sum of variances) fixed weights within
a study, and to specify a single value of within-study correlation ρ. Then the random vari-
ance component τ 2 can be estimated from the weighted residual sum of squares. Hedges
et al. (2010) recommend sensitivity analysis in respect of the influence of ρ values on the
estimated τ 2. They also provide a simulation study and an R program. Recommendation
to use inverse variance weights in the asymptotics K → ∞ with bounded sample sizes
seems to be rather risky. On the other hand, equal weights within a study would result
in an unbiased estimate of the covariance of bW (Rukhin, 2007), as long as the maximum
study weight wk < 1/2, and a simple correlation structure is a necessity in multivariate
meta-analysis when the covariances are not known, so overall this approach is a promising
development.
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5 Sequential meta analysis
The goal of meta-analysis is to combine evidence from various studies of the same effect
to provide a more reliable basis for decision making. However, any given meta-analysis
provides just a snapshot of the available evidence at a given point in time. At first there
may not be sufficient evidence for an effect, but as additional studies become available, the
significance of the new effect can be established. Detecting the moment when significance
is reached is a statistical problem also found in group sequential trials.
Further, temporal changes in effect sizes of substantial magnitude may occur, leading
to the loss or gain of statistical significance or even a change in the sign of the cumulative
mean effect. Such changes have been reported in medicine, ecology, the social sciences
and evolutionary biology. Factors initiating such change include time-lag bias, publication
bias, heterogeneity among studies, more effective research methods, paradigm shifts or
underlying changes in effects over time due to temporal changes in baseline values or
strength of causal agents (Koricheva and J., 2011).
These results suggest that results of meta-analyses conducted early in the process of
research accumulation should be interpreted with caution. Detection of temporal trends
in effect sizes is therefore an important methodological issue. Once temporal changes are
detected, one needs a model for this trend which will enable one to measure it. Cumulative
meta-analysis (CMA) was introduced in medical research to detect the earliest date for
which a treatment effect became statistically significant, and for which its clinical efficiency
could be evaluated (Lau et al., 1992). In a CMA studies are sorted in chronological order
and combined estimates of the effect θˆk and their confidence intervals are plotted and
scrutinized visually for possible temporal trends. As with all visual tools, CMA are subject
to misinterpretation and need to be supplemented by formal statistical methods. Such
methods should also take into account multiple testing inherent in CMA. Thus sequential
statistical methods are in order.
A recently proposed class of methods for detecting the moment when the significance is
reached is based on statistical methods developed for sequential clinical trials, Pogue and
Yusuf (1997); Brok et al. (2008); Wetterslev et al. (2008); van der Tweel and Bollen (2010);
Higgins et al. (2011). Group sequential methods define the Trial Sequential Monitoring
Boundaries based on prespecified type I and II errors and on clinically important effect.
Different types of monitoring boundaries can be used to stop the meta-analysis.
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Pogue and Yusuf (1997) adapted the Lan and DeMets (1983) alpha spending function
with O’Brien-Fleming boundaries to cumulative fixed effects meta-analysis. They defined
the Information Size (IS) as the sample size required to achieve power for one study under
the fixed effects model.
Brok et al. (2008) and Wetterslev et al. (2008) inflated these boundaries to accommodate
the random effects meta analysis. This method is called Trial Sequential Analysis (TSA).
The inflation coefficient is the ratio of sample sizes required under the REM and FEM.
Given that the sample size calculation under REM requires, in general, an increase in the
number of trials K (Goudie et al., 2010), this method appears too simplistic.
Several recent papers (van der Tweel and Bollen, 2010; Higgins et al., 2011) used group
sequential procedures by Whitehead (1999) and his package PEST in application to random
effects CMA. These procedures are designed to satisfy a pre-specified power requirement.
The main difference between TSA and these methods is the use of the sum of weights WK
as the IS instead of the sample size. Here the scaled cumulative effect Zk = Wkθk is plotted
against Wk, for an accumulated sum of weights Wk. A decision is made when the trajectory
crosses a monitoring boundary. Whitehead (1997) used the triangular design and van der
Tweel and Bollen (2010) used the double-triangular design. Higgins et al. (2011) use the
restricted procedure by Whitehead, equivalent to an O’Brian and Flemming stopping rule.
The theory of group sequential methods is based on an approximation of the trajectory
{Zk,Wk} by a Brownian motion. For the FEM, the increments Zk−Zk−1 are independent,
and this approximation is valid. For REM, these increments have a complicated correlation
structure resulting from dependencies between estimated random variance components τˆ 2k .
Thus an application of group sequential methods to random effects CMA is not justified
theoretically.
Lan et al. (2003) proposed to penalize the test statistic using the law of iterated loga-
rithm to account for multiple tests. Specifically, they propose to use Z∗k =
√
Wkθˆk/
√
λ ln ln(Wk)
for testing in the FEM, and Z∗∗k =
√
W ∗k θˆ
∗
k/
√
λ ln ln(W ∗k ) for the REM, where W
∗
k and
θˆ∗k correspond to accumulated sum of weights and the combined effect for the REM. The
penalizing constants λ are chosen from simulations to be 1.5 in the FEM, and 2 in the
REM.
A difficult related problem is an estimation of the variance component τ 2 when the
number of studies is small in the early stages of a cumulative meta-analysis. A semi-
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Bayesian method was proposed by Higgins et al. (2011). Lan et al. (2003) used the sample
variance of effects which is clearly overestimating τ 2 but helps to control the overall level
α.
Kulinskaya and Koricheva (2010) proposed the use of standard quality control (QC)
charts, in particular X¯ charts and CUSUM charts to detect possible outliers and trends
over time in meta-analysis. The CUSUM charts, equivalent to sequential likelihood ratio
tests, seem to be especially well suited for use in the CMA, both to assess significance, and
for detection of temporal trends. So far they were used only in the fixed effects model, but
a generalization of CUSUM charts to REM seems to be straightforward.
In order to model temporal trends, a number of papers used various regression ap-
proaches. Linear regression is used in Gehr et al. (2006) and Kampichler and Bruck-
ner (2009). Regression applied to consecutive combined effects is proposed in Bagos and
Nikolopoulos (2009). An exponential model of proportional decrease in effect is introduced
in Baker and Jackson (2010). So far there is no empirical evidence on the actual shapes of
temporal trends in effect sizes, and this is one more possible area of future work.
6 Available software packages
There are numerous packages, commercial, shareware and free, containing some meta-
analytic capabilities. Here we mention just several main contenders and provide some
further references.
The majority of systematic reviews in medicine and health sciences use meta-analytic
procedures included in Revman, the software by Cochrane Collaboration, now at version
5.2, http://ims.cochrane.org/revman. Description of the statistical methods used can be
found in Deeks and Higgins (2010). These are the basic procedures for univariate continu-
ous and binary data, and also some methods for meta-analysis of diagnostic tests accuracy.
The main commercial package is the Comprehensive Meta-Analysis (CMA), developed
by a group of experts specialising in meta-analysis. The package includes the standard uni-
variate methods, 1-factor or one covariate meta-regression, and cumulative meta-analysis,
along with a number of bias-detection tools. See Bax et al. (2007) for a review of seven
specialised software packages including the CMA. Comparison of the CMA to some pro-
grams available in SAS, SPSS, Excel and other general statistical software is given in
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http://www.meta-analysis.com/pages/comparisons.html.
A recently developed free package, the Meta-analyst (Wallace et al., 2009), includes the
same capabilities. The reference also includes a review of the existing software, against
which the Meta-analyst was extensively tested.
The main development of new statistical methods of meta-analysis is happening in
either Stata or R computational environment.
Stata includes a number of user-written packages, see Sterne (2009) and
http://www.stata.com/support/faqs/statistics/meta-analysis/ for the full list. The proce-
dures include both standard methods and various advanced options, such as multivariate
random-effects meta-analysis (White, 2009).
R has a similar array of continuously developing packages for meta-analysis. The main
three are meta by Guido Schwartzer, http://cran.r-project.org/web/packages/meta/meta.pdf,
metafor by Wolfgang Viechtbauer, http://www.metafor-project.org/, Viechtbauer (2009)
and mvmeta by Antonio Gasparrini, http://cran.r-project.org/web/packages/mvmeta/mvmeta.pdf,
Gasparrini et al. (2012). meta includes all standard univariate methods and some ex-
tensions; metafor additionally includes meta-regression, and a comprehensive array of
options for estimation in the random effects model; and mvmeta includes multivariate
meta-analysis.
7 Summary
The paper reviews the procedures and open problems in statistical meta-analysis. This is a
topic of growing importance, because in many areas of application the need for combining
different sources of data and different sources of information in order to reach an overall
assessment manifests itself. The classical material on meta-analytic statistical procedures
are reviewed in Section 2. These include the distinction between fixed and random effects
models, tests of homogeneity, and a discussion of the types of data typically available for
a meta-analysis. Section 3 investigates two sources of bias in meta-analysis, the bias due
to the systematic selection of studies showing stronger than average effects, and the meta-
analysis of smallish studies combined with the use of estimators with appreciable small
sample biases. In Sections 4 and 5 generalizations and extensions to the standard proce-
dures are discussed. They include meta-regression, multivariate responses and sequential
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procedures. A non-exhaustive list of software tools in Section 6 closes out the review.
A list of research problems for statisticians that we have identified follows:
1. Development of methods for the FEM that are based on the ‘actual likelihood’ (with-
out the assumptions of known within-study variances and normality). By ‘develop-
ment’, we mean both theoretical and simulation study analyses, as well as provision
of user-friendly software (Section 2.1).
2. The same problems exist for the REM, with the additional complication of estimating
inter-study variability. Properly standardized measures of heterogeneity and valid
tests for heterogeneity are yet to be developed for the REM. Alternative models such
as multiplicative ones should be investigated. (Section 2.4 and 2.3).
3. Investigation of actual likelihood models, or alternatively quasi-likelihood models
following transformations, which allow not only for moderators but additional inter-
study variation. For conceptual simplicity these models should reduce to the REM
when there are no significant moderators. (Section 2.5).
4. Modelling of biases in observational studies and further development of sensitivity
measures for such studies. (Section 2.7).
5. Although the qualitative issues regarding publication bias are well-understood, little
has been done to assess the degree of, and correct for, this widespread problem.
(Some detailed theory in this direction is provided in Section 3).
6. Removing the deleterious effect of small sample biases, as carried out in Section 3.2
for the one-sample binomial effects, for numerous other effects such as the relative
risk and odds ratio.
7. Multivariate meta-analysis and meta-regression methods promise to help solve a
broad range of problems in the health, social and medical sciences, as detailed in
Section 4.1. However, nearly all the research so far is based on the over-optimistic
assumptions of known covariance matrices and normality of errors. Much more pub-
licity needs to encourage gathering of covariate sample correlations, and modeling
of such to provide justification for assumed correlation structures. Again, sensitivity
measures for model miss-specification are sorely needed. As in the univariate case, de-
velopment of more realistic methodology for actual likelihood models presents many
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challenging problems, perhaps best solved on case by case basis in the context of the
same multivariate response data sets with similar covariates.
8. Although many of the above problems require more sophisticated attention, their as-
sumptions can be violated by temporal changes in effects, and so monitoring methods
and tests for such changes are required. When found, suitable meta-analyses with
built-in trends are required, especially to help in planning for future studies. Care-
ful asymptotics with attention to the rates at which within-study sample sizes grow
with the number of studies are required here, as in the above-described situations.
(Section 5.)
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Figure 3: Simulation study results showing bias and standard deviation of point estimates, to-
gether with coverage probabilities for the four intervals under comparison. The AC estimator
properties are depicted by solid lines, the BV estimator by dashed lines, the AS (arcsine) estima-
tor by dot-dashed lines and the ASBC (bias-corrected) estimator by dotted lines. The top left plot
shows the biases in the centers of the intervals when n = 20 and K = 1. Continuing with these
parameters, the top right plot depicts the standard deviations of the respective centre estimates.
Continuing, the bottom left plot shows the empirical coverages of nominal 95% confidence inter-
vals for p. The bottom right plot again shows empirical coverages of 95% confidence intervals,
but this time based on a standard meta-analysis that combines 5 studies each of size n = 20. See
text for more details and interpretation.
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